Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes

Metabolism: Clinical and Experimental

Volumn 54, Issue 3, 2005, Pages 281-286

  Inoue, Minoru ^a   Maehata, Eisuke ^b   Yano, Masao ^c   Taniyama, Matsuo ^a   Suzuki, Seiji ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b Prev Clin Laboratory Corporation   (Japan)

^c MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 13844262955     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.09.006     Document Type: Article

References (35)

1. T. Funahashi, T. Nakumura, I. Shimomura, K. Maeda, H. Kuriyama, and M. Takahashi Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity Int. Med. 38 1999 202 206
2. Y. Matsuzawa, T. Funahashi, and T. Nakamura Molecular mechanism of metabolic syndrome X: contribution of adipocyte-derived bioactive substances Ann. N. Y. Acad. Sci. 892 1999 146 154
3. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (adipose most abundant gene transcript 1) Biochem. Biophys. Res. Commun. 221 1996 286 289
4. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J. Biol. Chem. 270 1995 26746 26749
5. E. Hu, P. Liang, and B.M. Spigelman AdipoQ is a novel adipose-specific gene dysregulated in obesity J. Biol. Chem. 271 1996 10697 10703
6. Y. Nakano, T. Tobe, N.H. Choi-Miura, T. Mazda, and M. Tomita Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma J. Biol. Chem. 120 1996 803 812
7. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, and J. Miyagawa Paradoxical decrease of an adipose-specific protein, adiponectin in obesity Biochem. Biophys. Res. Comm. 257 1999 79 83
8. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Masuda, and Y. Okamoto Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler. Thromb. Vasc. Biol. 20 2000 1595 1599
9. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matuzawa, and R.E. PratLey Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J. Clin. Endocrinol. Metab. 24 2001 1930 1935
10. M. Inoue, E. Maehata, M. Taniyama, and S. Suzuki The role of adiponectin in patients with type 2 diabetes mellitus J. Anal. Bio-sci. 25 2003 145 152
11. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.F. Friedman Positional cloning of mouse obese gene and its human homologue Nature 372 1994 425 432
12. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, and M.R. Nyce Serum immunoreactive-leptin concentration in normal-weight and obese humans N. Engl. J. Med. 334 1996 292 295
13. I. Shimomura, R.E. Hammer, S. Ikemoto, M.S. Brown, and J.L. Goldstein Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 1999 73 76
14. C. Yang, O. Hiromi, N. Hayano, O. Keiko, Y. Takahashi, and Y. Yasuhiro Ratio of leptin to adiponectin as an obesity index of cynomolgus monkeys (Macaca fascicularis) Exp. Anim. 52 2 2003 137 143
15. C. Vigouroux, M. Maachi, T.H. Nguyen, C. Coussieu, S. Gharakhanian, and T. Funahashi Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy AIDS 17 10 2003 1503 1511
16. O.J. Pykalisto, P.H. Smith, and J.D. Brunxell Determinants of human adipose tissue lipoprotein lipase, effect of diabetes and obesity on basal- and diet-induced activity J. Clin. Invest. 56 1975 1108 1117
17. N.M. Kaplan The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension Arch. Intern. Med. 49 1989 1514 1520
18. R.A. DeFronzo Insulin resistance: multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerosis Neth. J. Med. 50 1997 191 197
19. J. Kobayashi, H. Hashimoto, I. Fukamachi, J. Tashiro, K. Shirai, and Y. Saito Lipoprotein lipase mass and activity in severe hypertriglyceridemia Clin. Chim. Acta. 216 1993 113 123
20. S.D. Prato, and P. Pozzilli FIRI: fasting or false insulin resistance index? Lancet 347 1996 132
21. T. Ono, N. Shiga, Y. Tanabe, and S. Umemura The fasting-plasma glucose range in which insulin resistance measured by homeostasis model assessment correlates with euglycemic clamping J. Jpn. Diabet. Soc. 42 1999 1005 1011
22. R.C. Turner, R.R. Holman, D. Matthews, T.D.R. Hockaday, and J. Peto Insulin deficiency and insulin resistance interaction in diabetes: estimation oh their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations Metabolism 28 1979 1086 1096
23. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
24. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am. J. Physiol. 237 1979 E214 E223
25. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetologia 28 1999 412 419
26. S.W. Shen, G.M. Reaven, and L.W. Farquhar Comparison of impedance to insulin-mediated glucose up take in normal subjects and in subjects with latent diabetes J. Clin. Invest. 49 1970 2151 2160
27. C.M. Ferrara, and A.P. Goldberg Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance Diabetes Care 24 2001 245 249
28. A. Katuki, Y. Sumida, H. Urakawa, E.C. Gabazza, S. Murashima, and K. Morioka Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus J. Clin. Endocrinol. Metab. 87 2002 5332 5335
29. A.H. Berg, T.P. Combs, and P.E. Scherer ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism Trends Endocrinol. Metab. 13 2002 84 89
30. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, and F.T. Yen Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 2005 2010
31. D.G. Baskin, J.E. Blevins, and M.W. Schwatz How the brain regulates food intake and body weight: the role of leptin J. Pediatr. Endocrinol. Meatab. 14 2001 1417 1419
32. G. Brabant, H. Nave, B. Mayr, M. Behrend, V. Harmelen, and P. Arner Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean obese women J. Clin. Endocrinol. Metab. 87 2002 3966 3970
33. W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, and C.L. Chao Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J. Clin. Endocrinol. Metab. 86 2001 3815 3819
34. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat. Med. 7 2001 941 946
35. A. Katsuki, Y. Sunida, E.C. Gabazza, S. Murashima, M. Furuta, and R. Araki-Sasaki Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes Diabetes Care 24 2001 362 365